The Ethics of Pharmaceutical Research Funding: A Social Organization Approach

From The Embassy of Good Science
Revision as of 21:52, 26 May 2020 by Marc.VanHoof (talk | contribs)
Cases

The Ethics of Pharmaceutical Research Funding: A Social Organization Approach

What is this about?

This is a fictional case which advances a social organization approach to examining unethical behavior. To illustrate the value of a social organization approach, a case study of a medical school professor's first experience with pharmaceutical-company-sponsored research is provided in order to examine how funding arrangements can constrain research integrity[1].

  1. Gray, Garry C. "The ethics of pharmaceutical research funding: A social organization approach." (2013): 629-634.

Why is this important?

While unethical behaviors may stem in part from failures in individual morality or psychological blind spots, they are both generated and performed through social interactions among individuals and groups[1]

  1. Gray, Garry C. "The ethics of pharmaceutical research funding: A social organization approach." (2013): 629-634.

For whom is this important?

Other information

Virtues & Values
Good Practices & Misconduct
Research Area
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6